REFERENCES
- AIDS Analysis Africa. AIDS Analysis Africa 1996; 6: 12–13, [CSA]
- Akbay P., Basaran A. A., Undeger U., Basaran N. In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L. Phytother. Res 2003; 17: 34–37, [INFOTRIEVE], [CSA], [CROSSREF]
- Akunyili D. N., Houghton P. J., Raman A. Antimicrobial activities of the stembark of Kigelia pinnata. J. Ethnopharmacol 1991; 35: 173–177, [INFOTRIEVE], [CSA], [CROSSREF]
- Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I., Gottesman M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol 1999; 39: 361–398, [INFOTRIEVE], [CSA], [CROSSREF]
- An. (2000). Medicinal Plants Forum for Commonwealth Africa: Centurion Lake Declaration, Cape Town, South Africa.
- An. (2005). Centurian Lake African Medicinal Plant Standards Meeting, Cape Town, South Africa.
- Anderson G. D., Rosito G., Mohustsy M. A., Elmer G. W. Drug interaction potential of soy extract and Panax ginseng. J. Clin. Pharmacol 2003; 43: 643–648, [INFOTRIEVE], [CSA], [CROSSREF]
- Appendino G., Bianchi F., Minassi A., Sterner O., Ballero M., Gibbons S. Oligomeric acylphloroglucinols from myrtle (Myrtus communis). J. Nat. Prod 2002; 65: 334–338, [INFOTRIEVE], [CSA], [CROSSREF]
- Arold G., Donath F., Maurer A., Diefenbach K., Bauer S., Henneicke-von Zepelin H. H., et al. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St. John's wort extract. Planta Med 2005; 71: 331–337, [INFOTRIEVE], [CSA], [CROSSREF]
- Barnes P. M., Powell-Griner E., McFann K., Nahin R. L. Complementary and alternative medicine use among adults: United States, 2002. Adv. Data 2004; 343: 1–19, [INFOTRIEVE], [CSA]
- Basch E., Ulbricht C., Hammerness P., Bevins A., Sollars D. Thyme (Thymus vulgaris L.), thymol. J. Herb. Pharmacother 2004; 4: 49–67, [INFOTRIEVE], [CSA], [CROSSREF]
- Bauer S., Stormer E., Johne A., Kruger H., Budde K., Neumayer H. H., et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St. John's wort in renal transplant patients. Br. J. Clin. Pharmacol 2003; 55: 203–211, [INFOTRIEVE], [CSA], [CROSSREF]
- Bedir E., Kirmizipekmez H., Sticher O., Calis I. Triterpene saponins from the fruits of Hedera helix. Phytochemistry 2000; 53: 905–909, [INFOTRIEVE], [CSA], [CROSSREF]
- Bertz R. J., Granneman G. R. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet 1997; 32: 210–258, [INFOTRIEVE], [CSA]
- Blumenthal M. Herbalgram: Cucurbita pepo. The Complete German Commission E Monographs—Therapeutic Guide to Herbal Medicines, M. Blumenthal, W. R. Busse, A. Goldberg, J. Gruenwald, H. Hall, C. W. Riggins, et al. American Botanical Council and Boston: Integrative Medicine Communications, Austin 1998
- Bongartz D., Hesse A. Selective extraction of quercetrin in vegetable drugs and urine by off-line coupling of boronic acid affinity chromatography and high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl 1995; 673: 223–230, [INFOTRIEVE], [CSA], [CROSSREF]
- Borrelli F., Izzo A. A., Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci 2003; 73: 1215–1229, [INFOTRIEVE], [CSA], [CROSSREF]
- Bray B. J., Perry N. B., Menkes D. B., Rosengren R. J. St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse. Toxicol. Sci 2002; 66: 27–33, [INFOTRIEVE], [CSA], [CROSSREF]
- Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7: 273–282, [INFOTRIEVE], [CSA]
- Cantoni L., Rozio M., Mangolini A., Hauri L., Caccia S. Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse. Toxicol. Sci 2003; 75: 25–30, [INFOTRIEVE], [CSA], [CROSSREF]
- Cascorbi I. Pharmacogenetics of cytochrome p4502D6: genetic background and clinical implication. Eur. J. Clin. Invest 2003; 33(suppl 2)17–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Castro A. F., Altenberg G. A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem. Pharmacol 1997; 53: 89–93, [INFOTRIEVE], [CSA], [CROSSREF]
- Chang Q., Zuo Z., Harrison F., Chow M. S. Hawthorn. J. Clin. Pharmacol 2002; 42: 605–612, [INFOTRIEVE], [CSA], [CROSSREF]
- Chen C. C., Huang Y. L., Sun C. M., Shen C. C. New prenylflavones from the leaves of Epimedium saggitatum. J. Nat. Prod 1996; 59: 412–414, [INFOTRIEVE], [CSA], [CROSSREF]
- Chen C. J., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–389, [INFOTRIEVE], [CSA], [CROSSREF]
- Chiba M., Hensleigh M., Nishime J. A., Balani S. K., Lin J. H. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metab. Dispos 1996; 24: 307–314, [INFOTRIEVE], [CSA]
- Chrubasik S., Pittler M. H., Roufogalis B. D. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005; 12: 684–701, [INFOTRIEVE], [CSA], [CROSSREF]
- de los Reyes G. C., Koda R. T. Determining hyperforin and hypericin content in eight brands of St. John's wort. Am. J. Health Syst. Pharm 2002; 59: 545–547, [INFOTRIEVE], [CSA]
- de Maat M. M., Ekhart G. C., Huitema A. D., Koks C. H., Mulder J. W., Beijnen J. H. Drug interactions between antiretroviral drugs and comedicated agents. Clin. Pharmacokinet 2003a; 42: 223–282, [INFOTRIEVE], [CSA], [CROSSREF]
- de Maat M. M., Ekhart G. C., Huitema A. D., Koks C. H., Mulder J. W., Beijnen J. H. Drug interactions between antiretroviral drugs and comedicated agents. Clin. Pharmacokinet 2003b; 42: 223–282, [INFOTRIEVE], [CSA], [CROSSREF]
- de Maat M. M., Hoetelmans R. M., Math T. R. A., van Gorp E. C., Meenhorst P. L., Mulder J. W., et al. Drug interaction between St. John's wort and nevirapine. AIDS 2001; 15: 420–421, [INFOTRIEVE], [CSA], [CROSSREF]
- Deferme S., Kamuhabwa A., Nshimo C., de Witte P., Augustijns P. Screening of Tanzanian plant extracts for their potential inhibitory effect on P-glycoprotein mediated efflux. Phytother. Res 2003; 17: 459–464, [INFOTRIEVE], [CSA], [CROSSREF]
- DiCenzo R., Shelton M., Jordan K., Koval C., Forrest A., Reichman R., et al. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003; 23: 866–870, [INFOTRIEVE], [CSA], [CROSSREF]
- Donovan J. L., Chavin K. D., DeVane C. L., Taylor R. M., Wang J. S., Ruan Y., et al. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab. Dispos 2004a; 32: 906–908, [INFOTRIEVE], [CSA], [CROSSREF]
- Donovan J. L., DeVane C. L., Chavin K. D., Taylor R. M., Markowitz J. S. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab. Dispos 2003; 31: 519–522, [INFOTRIEVE], [CSA], [CROSSREF]
- Donovan J. L., DeVane C. L., Chavin K. D., Wang J. S., Gibson B. B., Gefroh H. A., et al. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab. Dispos 2004b; 32: 1333–1336, [INFOTRIEVE], [CSA], [CROSSREF]
- Dresser G. K., Schwarz U. I., Wilkinson G. R., Kim R. B. Coordinate induction of both cytochrome P4503A and MDR1 by St. John's wort in healthy subjects. Clin. Pharmacol. Ther 2003; 73: 41–50, [INFOTRIEVE], [CSA], [CROSSREF]
- Dulloo A. G., Duret C., Rohrer D., Girardier L., Mensi N., Fathi M., et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr 1999; 70: 1040–1045, [INFOTRIEVE], [CSA]
- Durr D., Stieger B., Kullak-Ublick G. A., Rentsch K. M., Steinert H. C., Meier P. J., et al. St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther 2000; 68: 598–604, [INFOTRIEVE], [CSA], [CROSSREF]
- Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van R. M., et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 1998; 280: 1569–1575, [INFOTRIEVE], [CSA], [CROSSREF]
- el-Sissi H. I., el-Ansary M. A. Tannins and polyphenolics of the leaves of Myrtus communis. Planta Med 1967; 15: 41–51, [INFOTRIEVE], [CSA]
- EMEA. Eucalyptus Globulus, Summary Report. Veterinary medicines evaluation unit, LondonUK 1999
- Ereshefsky B., Gewertz N., Lam Y.W.F., et al. Determination of SJW Differential Metabolism at CYP2D6 and CYP3A4, Using Dextrometorphan Probe Methodology. Presented at the NCDEU 39th Annual Meeting, Boca Raton, FL, 1999
- Erlund I., Marniemi J., Hakala P., Alfthan G., Meririnne E., Aro A. Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations. Eur. J. Clin. Nutr 2003; 57: 37–42, [INFOTRIEVE], [CSA], [CROSSREF]
- Ernst E. Complementary AIDS therapies: the good, the bad and the ugly. Int. J. STD AIDS 1997; 8: 281–285, [INFOTRIEVE], [CSA], [CROSSREF]
- Fairfield K. M., Eisenberg D. M., Davis R. B., Libman H., Phillips R. S. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch. Intern. Med 1998; 158: 2257–2264, [INFOTRIEVE], [CSA], [CROSSREF]
- Foster B. C., Foster M. S., Vandenhoek S., Krantis A., Budzinski J. W., Arnason J. T., et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J. Pharm. Pharm. Sci 2001; 4: 176–184, [INFOTRIEVE], [CSA]
- Gallicano K., Foster B., Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br. J. Clin. Pharmacol 2003; 55: 199–202, [INFOTRIEVE], [CSA], [CROSSREF]
- Ganzera M., Zhao J., Khan I. A. Hypericum perforatum—chemical profiling and quantitative results of St. John's wort products by an improved high-performance liquid chromatography method. J. Pharm. Sci 2002; 91: 623–630, [INFOTRIEVE], [CSA], [CROSSREF]
- Goodwin B., Moore L. B., Stoltz C. M., McKee D. D., Kliewer S. A. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol. Pharmacol 2001; 60: 427–431, [INFOTRIEVE], [CSA]
- Gorski J. C., Huang S. M., Pinto A., Hamman M. A., Hilligoss J. K., Zaheer N. A., et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin. Pharmacol. Ther 2004; 75: 89–100, [INFOTRIEVE], [CSA], [CROSSREF]
- Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem 1993; 62: 385–427, [INFOTRIEVE], [CSA], [CROSSREF]
- Govindachari T. R., Patankar S. J., Visnawathan N. Isolation and structure of two new dihydroisocoumarins from Kigelia pinnata. Phytochemistry 1971; 10: 1603–1606, [CSA], [CROSSREF]
- Guillaume M., Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 1994; 44: 25–35, [INFOTRIEVE], [CSA]
- Gunther M., Schmidt P. C. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts. J. Pharm. Biomed. Anal 2005; 37: 817–821, [INFOTRIEVE], [CSA], [CROSSREF]
- Gurley B., Barone G. W., Williams D. K., Carrier J., Breen P., Yates C. R., et al. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab. Dispos 2005a; 34: 69–74, [INFOTRIEVE], [CSA]
- Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Carrier J., et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin. Pharmacol. Ther 2004; 76: 428–440, [INFOTRIEVE], [CSA]
- Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Cui Y., et al. Cytochrome P450 phenotypic ratios for predicting herb–drug interactions in humans. Clin. Pharmacol. Ther 2002; 72: 276–287, [INFOTRIEVE], [CSA], [CROSSREF]
- Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Cui Y., et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St. John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005b; 22: 525–539, [INFOTRIEVE], [CSA], [CROSSREF]
- Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Khan I. A., et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin. Pharmacol. Ther 2005c; 77: 415–426, [INFOTRIEVE], [CSA], [CROSSREF]
- Gyllenhaal C., Merritt S. L., Peterson S. D., Block K. I., Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med. Rev 2000; 4: 229–251, [INFOTRIEVE], [CSA], [CROSSREF]
- Hartel U., Volger E. Use and acceptance of classical natural and alternative medicine in Germany—findings of a representative population-based survey. Forsch. Komplementarmed. Klass. Naturheilkd 2004; 11: 327–334, [INFOTRIEVE], [CSA], [CROSSREF]
- He H., Edeki T. Effects of ginseng and Ginkgo biloba components on CYP2C9 mediated tolbutamide 4-methyl-hydroxylation in human liver microsomes. Clin. Pharmacol. Ther 2002; 71: 67, (abstr. Tp-II96)[CSA]
- He H., Edeki T. Effects of ginseng and Ginkgo biloba components on CYP3A4 mediated testosterone 6beta-hydroxylation in human liver microsomes. Clin. Pharmacol. Ther 2003; 73: 50, (abstr. pII-8)[CSA]
- Henderson G. L., Harkey M. R., Gershwin M. E., Hackman R. M., Stern J. S., Stresser D. M. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 1999; 65: L209–L214, [CSA], [CROSSREF]
- Hennessy M., Kelleher D., Spiers J. P., Barry M., Kavanagh P., Back D., et al. St. Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br. J. Clin. Pharmacol 2002; 53: 75–82, [INFOTRIEVE], [CSA], [CROSSREF]
- Hiller K., Genzel S., Murach M., Franke P. [Knowledge of saponins of genus Solidago. 1. Saponins of Solidago virgaurea L.]. Pharmazie 1975; 30: 188–190, [INFOTRIEVE], [CSA]
- Ho P. C., Saville D. J., Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J. Pharm. Pharm. Sci 2001; 4: 217–227, [INFOTRIEVE], [CSA]
- Hsu A., Granneman G. R., Bertz R. J. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin. Pharmacokinet 1998; 35: 275–291, [INFOTRIEVE], [CSA], [CROSSREF]
- Hu Z., Yang X., Ho P. C., Chan S. Y., Heng P. W., Chan E., et al. Herb–drug interactions: a literature review. Drugs 2005; 65: 1239–1282, [INFOTRIEVE], [CSA], [CROSSREF]
- Inouye K., Inouye H., Chan C. C. A naphthoquinone and a lignan from the wood of Kigelia pinnata. Phytochemistry 1981; 20: 2271–2276, [CSA], [CROSSREF]
- Izzo A. A. Herb–drug interactions: an overview of the clinical evidence. Fundam. Clin. Pharmacol 2005; 19: 1–16, [INFOTRIEVE], [CSA], [CROSSREF]
- Jager W., Zembsch B., Wolschann P., Pittenauer E., Senderowicz A. M., Sausville E. A., et al. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver. Life Sci 1998; 62: 1861–1873, [INFOTRIEVE], [CSA], [CROSSREF]
- Janetzky K., Morreale A. P. Probable interaction between warfarin and ginseng. Am. J. Health Syst. Pharm 1997; 54: 692–693, [INFOTRIEVE], [CSA]
- Jiang X., Williams K. M., Liauw W. S., Ammit A. J., Roufogalis B. D., Duke C. C., et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol 2005; 59: 425–432, [INFOTRIEVE], [CSA], [CROSSREF]
- Joshi K. C., Sing P., Taneja S., Cox P. J., Allan-Howie R., Thomson R. H. New terpenoid aldehydes from Kigelia pinnata: crystal structure of pinnatal. Tetrahedron 1983; 38: 2703–2708, [CSA], [CROSSREF]
- Kaminsky L. S., Zhang Z. Y. Human P450 metabolism of warfarin. Pharmacol. Ther 1997; 73: 67–74, [INFOTRIEVE], [CSA], [CROSSREF]
- Kaufman D. W., Kelly J. P., Rosenberg L., Anderson T. E., Mitchell A. A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287: 337–344, [INFOTRIEVE], [CSA], [CROSSREF]
- Kiang T. K., Ensom M. H., Chang T. K. UDP-glucuronosyltransferases and clinical drug–drug interactions. Pharmacol. Ther 2005; 106: 97–132, [INFOTRIEVE], [CSA], [CROSSREF]
- Kilima P. M., Ostermayer I., Shija M., Wolff M. M., Evans P. J. Drug Utilization, Prescribing Habits and Patients in City Council Health Facilities, Dar es Salaam, Tanzania. DUHP, Swiss Tropical Institute, Basel 1993; 19
- Kim A. E., Dintaman J. M., Waddell D. S., Silverman J. A. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. J. Pharmacol. Exp. Ther 1998a; 286: 1439–1445, [INFOTRIEVE], [CSA]
- Kim R. B., Fromm M. F., Wandel C., Leake B., Wood A. J., Roden D. M., et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest 1998b; 101: 289–294, [INFOTRIEVE], [CSA]
- Kim S. H., Yeo G. S., Lim Y. S., Kang C. D., Kim C. M., Chung B. S. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp. Mol. Med 1998c; 30: 87–92, [INFOTRIEVE], [CSA]
- Knutter S., Pohloudek-Fabini R. [Contents of etheric oil of the roots of Solidago virgaurea L. 19. Microanalytics of etheric oils]. Pharmazie 1969; 24: 409–411, [INFOTRIEVE], [CSA]
- Kruth P., Brosi E., Fux R., Morike K., Gleiter C. H. Ginger-associated overanticoagulation by phenprocoumon. Ann. Pharmacother 2004; 38: 257–260, [INFOTRIEVE], [CSA]
- Laroche M, Choudhri S., Gallicano K., Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can. J. Infect. Dis 1998; 9: 471P, [CSA]
- Lefebvre T., Foster B. C., Drouin C. E., Krantis A., Livesey J. F., Jordan S. A. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J. Pharm. Pharm. Sci 2004; 7: 265–273, [INFOTRIEVE], [CSA]
- Liu J., Burdette J. E., Sun Y., Deng S., Schlecht S. M., Zheng W., et al. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004; 11: 18–23, [INFOTRIEVE], [CSA], [CROSSREF]
- Lu H., Meng X., Li C., Sang S., Patten C., Sheng S., et al. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab. Dispos 2003; 31: 452–461, [INFOTRIEVE], [CSA], [CROSSREF]
- Mai I., Bauer S., Perloff E. S., Johne A., Uehleke B., Frank B., et al. Hyperforin content determines the magnitude of the St. John's wort–cyclosporine drug interaction. Clin. Pharmacol. Ther 2004; 76: 330–340, [INFOTRIEVE], [CSA], [CROSSREF]
- Markowitz J. S., DeVane C. L., Boulton D. W., Carson S. W., Nahas Z., Risch S. C. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci 2000; 66: L133–L139, [CSA], [CROSSREF]
- Markowitz J. S., DeVane C. L., Chavin K. D., Taylor R. M., Ruan Y., Donovan J. L. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin. Pharmacol. Ther 2003a; 74: 170–177, [INFOTRIEVE], [CSA], [CROSSREF]
- Markowitz J. S., Donovan J. L., DeVane C. L., Taylor R. M., Ruan Y., Wang J. S., et al. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin. Pharmacol. Ther 2003b; 74: 536–542, [INFOTRIEVE], [CSA], [CROSSREF]
- Matheny C. J., Ali R. Y., Yang X., Pollack G. M. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues. Drug Metab. Dispos 2004; 32: 1008–1014, [INFOTRIEVE], [CSA]
- Menniti-Ippolito F., Gargiulo L., Bologna E., Forcella E., Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur. J. Clin. Pharmacol 2002; 58: 61–64, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Cooper C., Kanfer I. Traditional African medicine in the treatment of HIV. Lancet Infect. Dis 2005a; 5: 465–467, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Cooper C., Seely D., Kanfer I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr. J 2005b; 4: 19, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Foster B. C., van H. R., Phillips E., Wilson K, Leonard B, et al. Impact of African herbal medicines on antiretroviral metabolism. AIDS 2005c; 19: 95–97, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Montori V., Perri D., Phillips E., Koren G. Natural health product-HIV drug interactions: a systematic review. Int. J. STD AIDS 2005d; 16: 181–186, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Wilson K., Clarke M., Foster B., Walker S., Rachlis B., et al. Milk thistle and indinavir: a randomized controlled pharmacokinetics study and meta-analysis. Eur. J. Clin. Pharmacol 2005e; 61: 1–7, [INFOTRIEVE], [CSA], [CROSSREF]
- Mills E., Wu P., Johnston B. C., Gallicano K., Clarke M., Guyatt G. Natural health product-drug interactions: a systematic review of clinical trials. Ther. Drug Monit 2005f; 27: 549–557, [INFOTRIEVE], [CSA], [CROSSREF]
- Monograph. Petasites hybridus. Altern. Med. Rev 2001; 6: 207–209, [CSA]
- Moore L. B., Goodwin B., Jones S. A., Wisely G. B., Serabjit-Singh C. J., Willson T. M., et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 2000; 97: 7500–7502, [INFOTRIEVE], [CSA], [CROSSREF]
- Nishikawa M., Ariyoshi N., Kotani A., Ishii I., Nakamura H., Nakasa H., et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab. Pharmacokinet 2004; 19: 280–289, [INFOTRIEVE], [CSA], [CROSSREF]
- Noldner M., Chatterjee S. Effects of two different extracts of St. John's wort and some of their constituents on cytochrome P450 activities in rat liver microsomes. Pharmacopsychiatry 2001; 34(suppl 1)S108–S110, [INFOTRIEVE], [CSA], [CROSSREF]
- Obach R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression. J. Pharmacol. Exp. Ther 2000; 294: 88–95, [INFOTRIEVE], [CSA]
- Ohnishi N., Kusuhara M., Yoshioka M., Kuroda K., Soga A., Nishikawa F., et al. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats. Biol. Pharm. Bull 2003; 26: 1315–1320, [INFOTRIEVE], [CSA], [CROSSREF]
- Okoli A. S., Okeke M. I., Iroegbu C. U., Ebo P. U. Antibacterial activity of Harungana madagascariensis leaf extracts. Phytother. Res 2002; 16: 174–179, [INFOTRIEVE], [CSA]
- Okome-Nkoumou M., Okome-Miame F., Kendjo E., Obiang G. P., Kouna P., Essola-Biba O., et al. Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, Gabon. HIV. Clin. Trials 2005; 6: 38–42, [INFOTRIEVE], [CSA]
- Ouzzine M., Pillot T., Fournel-Gigleux S., Magdalou J., Burchell B., Siest G. Expression and role of the human liver UDP-glucuronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in. Escherichia coli. Arch. Biochem. Biophys 1994; 310: 196–204, [CSA], [CROSSREF]
- Patel J., Buddha B., Dey S., Pal D., Mitra A. K. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am. J. Ther 2004; 11: 262–277, [INFOTRIEVE], [CSA], [CROSSREF]
- Perloff M. D., von Moltke L. L., Stormer E., Shader R. I., Greenblatt D. J. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br. J. Pharmacol 2001; 134: 1601–1608, [INFOTRIEVE], [CSA], [CROSSREF]
- Piscitelli S. C., Burstein A. H., Chaitt D., Alfaro R. M., Falloon J. Indinavir concentrations and St. John's wort. Lancet 2000; 355: 547–548, [INFOTRIEVE], [CSA], [CROSSREF]
- Piscitelli S. C., Burstein A. H., Welden N., Gallicano K. D., Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis 2002a; 34: 234–238, [INFOTRIEVE], [CSA], [CROSSREF]
- Piscitelli S. C., Formentini E., Burstein A. H., Alfaro R., Jagannatha S., Falloon J. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002b; 22: 551–556, [INFOTRIEVE], [CSA], [CROSSREF]
- Rajnarayana K., Reddy M. S., Vidyasagar J., Krishna D. R. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole. Arzneimittelforschung 2004; 54: 109–113, [INFOTRIEVE], [CSA]
- Raucy J. L. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab. Dispos 2003; 31: 533–539, [INFOTRIEVE], [CSA], [CROSSREF]
- Roby C. A., Anderson G. D., Kantor E., Dryer D. A., Burstein A. H. St. John's wort: effect on CYP3A4 activity. Clin. Pharmacol. Ther 2000; 67: 451–457, [INFOTRIEVE], [CSA], [CROSSREF]
- Roby C. A., Dryer D. A., Burstein A. H. St. John's wort: effect on CYP2D6 activity using dextromethorphan-dextrorphan ratios. J. Clin. Psychopharmacol 2001; 21: 530–532, [INFOTRIEVE], [CSA], [CROSSREF]
- Rosado M. F. Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product. Cardiology 2003; 99: 111, [INFOTRIEVE], [CSA], [CROSSREF]
- Sato M., Maulik G., Ray P. S., Bagchi D., Das D. K. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J. Mol. Cell Cardiol 1999; 31: 1289–1297, [INFOTRIEVE], [CSA], [CROSSREF]
- Sebit M. B., Chandiwana S. K., Latif A. S., Gomo E., Acuda S. W., Makoni F., et al. Quality of life evaluation in patients with HIV-I infection: the impact of traditional medicine in Zimbabwe. Cent. Afr. J. Med 2000; 46: 208–213, [INFOTRIEVE], [CSA]
- Selawry O. S., Vester F., Mai W., Schwartz M. R. [On the identification of the constituents of Viscum album. II. Tumor inhibiting substances.]. Hoppe Seylers. Z. Physiol. Chem 1961; 324: 262–281, [INFOTRIEVE], [CSA]
- Shelton R. C. St. John's wort for the treatment of depression. Lancet Neurol 2002; 1: 275, [INFOTRIEVE], [CSA], [CROSSREF]
- Shimada H., Tyler V. E., McLaughlin J. L. Biologically active acylglycerides from the berries of saw-palmetto (Serenoa repens). J. Nat. Prod 1997; 60: 417–418, [INFOTRIEVE], [CSA], [CROSSREF]
- Shinozuka K., Umegaki K., Kubota Y., Tanaka N., Mizuno H., Yamauchi J., et al. Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci 2002; 70: 2783–2792, [INFOTRIEVE], [CSA], [CROSSREF]
- Slain D., Pakyz A., Israel D. S., Monroe S., Polk R. E. Variability in activity of hepatic CYP3A4 in patients infected with HIV. Pharmacotherapy 2000; 20: 898–907, [INFOTRIEVE], [CSA], [CROSSREF]
- Snyman T., Stewart M. J., Grove A., Steenkamp V. Adulteration of South African traditional herbal remedies. Ther. Drug Monit 2005; 27: 86–89, [INFOTRIEVE], [CSA], [CROSSREF]
- Sohn O. S., Surace A., Fiala E. S., Richie J. P., Jr., Colosimo S., Zang E. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica 1994; 24: 119–127, [INFOTRIEVE], [CSA]
- South African Development Committee. (2002). Ministerial consultative meeting on nutrition and HIV/AIDS, Johannesburg, South Africa, January 20.
- Sparber A., Wootton J. C., Bauer L., Curt G., Eisenberg D., Levin T., et al. Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J. Altern. Complement. Med 2000; 6: 415–422, [INFOTRIEVE], [CSA]
- Sparreboom A., Cox M. C., Acharya M. R., Figg W. D. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J. Clin. Oncol 2004; 22: 2489–2503, [INFOTRIEVE], [CSA], [CROSSREF]
- Standish L. J., Greene K. B., Bain S., Reeves C., Sanders F., Wines R. C., et al. Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care 2001; 13: 197–208, [INFOTRIEVE], [CSA], [CROSSREF]
- Sugiyama T., Kubota Y., Shinozuka K., Yamada S., Yamada K., Umegaki K. Induction and recovery of hepatic drug metabolizing enzymes in rats treated with Ginkgo biloba extract. Food Chem. Toxicol 2004; 42: 953–957, [INFOTRIEVE], [CSA], [CROSSREF]
- Sweetnam S. Phytosterols. Martindale: The Complete Drug Reference. Pharmaceutical Press, London 2006; 870
- Tankanow R., Tamer H. R., Streetman D. S., Smith S. G., Welton J. L., Annesley T., et al. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J. Clin. Pharmacol 2003; 43: 637–642, [INFOTRIEVE], [CSA], [CROSSREF]
- Teng C. M., Kuo S. C., Ko F. N., Lee J. C., Lee L. G., Chen S. C., et al. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng. Biochim. Biophys. Acta 1989; 990: 315–320, [INFOTRIEVE], [CSA]
- Tona L., Kambu K., Ngimbi N., Cimanga K., Vlietinck A. J. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J. Ethnopharmacol 1998; 61: 57–65, [INFOTRIEVE], [CSA], [CROSSREF]
- Tsukamoto S., Aburatani M., Ohta T. Isolation of CYP3A4 Inhibitors from the black cohosh (Cimicifuga racemosa). Evid. Based Complement. Alternat. Med 2005; 2: 223–226, [INFOTRIEVE], [CSA], [CROSSREF]
- Unger M., Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun. Mass Spectrom 2004; 18: 2273–2281, [INFOTRIEVE], [CSA], [CROSSREF]
- Usia T., Watabe T., Kadota S., Tezuka Y. Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus. Biol. Pharm. Bull 2005; 28: 1021–1024, [INFOTRIEVE], [CSA], [CROSSREF]
- van Erp, N. P. H., Baker, S., Zhao, M., Rudek, M., Guchelaar, H., Nortier, J., et al. (2005). Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan, Figon dutch medicines days, Congress Hotel de Werelt, Lunteren.
- van Roon E. N., Flikweert S., Le C. M., Langendijk P. N., Kwee-Zuiderwijk W. J., Smits P., et al. Clinical relevance of drug–drug interactions: a structured assessment procedure. Drug Saf 2005; 28: 1131–1139, [INFOTRIEVE], [CSA], [CROSSREF]
- van Wijk B., van Oudshoorn B., Gerken G. Medicinal Plants of South Africa. Briza Publications, Pretoria 1997
- Vester F., Mai W. [On the identification of the constituents of Viscum album. I. Free amino acids.]. Hoppe Seylers. Z. Physiol Chem 1960; 322: 273–277, [INFOTRIEVE], [CSA]
- Vigo E., Cepeda A., Gualillo O., Perez-Fernandez R. In-vitro anti-inflammatory effect of Eucalyptus globulus and Thymus vulgaris: nitric oxide inhibition in J774A.1 murine macrophages. J. Pharm. Pharmacol 2004; 56: 257–263, [INFOTRIEVE], [CSA], [CROSSREF]
- Wang Z., Gorski J. C., Hamman M. A., Huang S. M., Lesko L. J., Hall S. D. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin. Pharmacol. Ther 2001; 70: 317–326, [INFOTRIEVE], [CSA], [CROSSREF]
- Weidner M. S., Sigwart K. The safety of a ginger extract in the rat. J. Ethnopharmacol 2000; 73: 513–520, [INFOTRIEVE], [CSA], [CROSSREF]
- Wentworth J. M., Agostini M., Love J., Schwabe J. W., Chatterjee V. K. St. John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol 2000; 166: R11–R16, [INFOTRIEVE], [CSA], [CROSSREF]
- Wurglics M., Westerhoff K., Kaunzinger A., Wilke A., Baumeister A., Dressman J., et al. Comparison of German St. John's wort products according to hyperforin and total hypericin content. J. Am. Pharm. Assoc. (Wash.) 2001; 41: 560–566, [CSA]
- Wuttke W., Jarry H., Christoffel V., Spengler B., Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)—pharmacology and clinical indications. Phytomedicine 2003; 10: 348–357, [INFOTRIEVE], [CSA], [CROSSREF]
- Xie R, Tan L. H., Polasek E. C., Hong C., Teillol-Foo M., Gordi T., et al. CYP3A and P‐glycoprotein induction with St. John's wort in healthy volunteers of selected ethnic populations. Clin. Pharmacol. Ther 2003; 73: P93, [CSA]
- Yale S. H., Glurich I. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J. Altern. Complement. Med 2005; 11: 433–439, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang C. S., Yang G. Y., Landau J. M., Kim S., Liao J. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp. Lung Res 1998; 24: 629–639, [INFOTRIEVE], [CSA]
- Yuan C. S., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann. Intern. Med 2004; 141: 23–27, [INFOTRIEVE], [CSA]
- Zachariah R., Nkhoma W., Harries A. D., Arendt V., Chantulo A., Spielmann M. P., et al. Health seeking and sexual behaviour in patients with sexually transmitted infections: the importance of traditional healers in Thyolo, Malawi. Sex. Transm. Infect 2002; 78: 127–129, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhong Z., Froh M., Connor H. D., Li X., Conzelmann L. O., Mason R. P., et al. Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am. J. Physiol. Gastrointest. Liver Physiol 2002; 283: G957–G964, [INFOTRIEVE], [CSA]
- Zhou S., Gao Y., Jiang W., Huang M., Xu A., Paxton J. W. Interactions of herbs with cytochrome P450. Drug Metab. Rev 2003; 35: 35–98, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhou S., Lim L. Y., Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev 2004; 36: 57–104, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhu M., Chan K. W., Ng L. S., Chang Q., Chang S., Li R. C. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J. Pharm. Pharmacol 1999; 51: 175–180, [INFOTRIEVE], [CSA], [CROSSREF]
- Zou L., Harkey M. R., Henderson G. L. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 2002; 71: 1579–1589, [INFOTRIEVE], [CSA], [CROSSREF]